It's the Brian Laris Show on WNYC. Good morning again, everyone. Now we continue with a special edition of our series, 100 Years of 100 Things. It's 100 years of cancer research.

Before the news, we did the straight 100 years treatment on the century of developments

in identifying, preventing, and treating different cancers.

Now we will land squarely in the present to convene a discussion of what should happen this year and beyond

at a time when cancer research funding is being cut as a policy of what should happen this year and beyond at a time when cancer research

funding is being cut as a policy of the Trump administration, the American Cancer Society

says cut by 37%. And again, the context for this is that each year, WNYC's local news division

hosts a health convening with support from the Alfred P. Sloan Foundation.

The convening has typically been an opportunity for health care experts and practitioners to inform WNYC's

health reporting in an off-the-air briefing and interaction. But again, this year, as we did last year on the show,

we're bringing it on to the air,

as we think it'll be a service for you to hear the briefing too.

So with us now on the current state of cancer research in the United States,

scientifically and politically, are Suta Parique, PhD, CEO of the American Association

for the Advancement of Science, the AAAS, an executive publisher

of the journal Science and other journals the AAAS publishes.

Otis Brawley, professor of oncology at the Kimmel Cancer Center at the Johns Hopkins University

School of Medicine, and co-editor of the Cancer History Project that our

guest before the news was also associated with. And Julie Rovner, Chief Washington correspondent

at KFF Health News and host of their podcast, What the Health, Julia, as some of you know,

previously covered health news for NPR. So Julie, welcome

back. Dr. Brawley, Dr. Parique, welcome to WNYC. Thanks for having me. Thank you. And Dr.

...